EYPT

EyePoint, Inc.
NasdaqGMUSDEQUITY Healthcare DELAYED
Last price
3.17
▲ 0.02 (0.63%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.15
Prev close
3.15
Day high
3.29
Day low
3.08
Volume
1.98M
Market cap
$265.78M
P/E (TTM)
—
52W range
3.05 – 19.11

Day trading desk

Current session · delayed
Gap from prior close
-0.00%
Prior close 3.15
VWAP
3.17
+0.14% from price
Relative volume
0.85×
Normal
Session range
6.99%
3.08 – 3.29
Position in range
44%
Mid range
ATR (14D)
0.27
8.65% of price
Prior day high
3.28
PDH
Prior day low
3.05
PDL
Bid / ask spread
—
Quote not published
Session volume
3.32M
Avg 3.92M

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-7.31% -9.3%
1M
-30.79% -31.9%
3M
-77.37% -81.9%
6M
-76.64% -94.8%
YTD
-82.65% -96.9%
1Y
-76.91% -93.3%
3Y
-60.33% -142.6%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on EYPT open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
+99.72K
Net buying
Buy transactions
6
107.03K shares
Sell transactions
2
7.31K shares
Net transactions
+8
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
3.04M
Total on file
Bought 107.03KSold 7.31K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 20, 26
ELSTON GEORGE O
Chief Financial Officer
STOCK 64.95K $0 Direct
Aug 18, 26
ZADEREJ KAREN L
Director
BUY 10.60K $52.26K Direct
Jul 10, 26
DUKER JAY S
Chief Executive Officer
— 16.67K — Direct
Jun 30, 26
RIBEIRO RAMIRO
Officer
CONVERSION 4.88K $40.27K Direct
Jun 30, 26
RIBEIRO RAMIRO
Officer
SELL 4.88K $73.17K Direct
May 22, 26
ELSTON GEORGE O
Chief Financial Officer
— 7.50K — Direct
Apr 17, 26
RIBEIRO RAMIRO
Officer
CONVERSION 2.44K $20.13K Direct
Apr 17, 26
RIBEIRO RAMIRO
Officer
SELL 2.44K $36.55K Direct
Mar 16, 26
DUKER JAY S
Chief Executive Officer
BUY 1.50K $19.72K Indirect
Mar 4, 26
RIBEIRO RAMIRO
Officer
CONVERSION 2.44K $20.14K Direct
Mar 4, 26
RIBEIRO RAMIRO
Officer
SELL 2.44K $43.57K Direct
Mar 2, 26
ELSTON GEORGE O
Chief Financial Officer
STOCK 5.00K $0 Direct
Feb 17, 26
RIBEIRO RAMIRO
Officer
CONVERSION 2.44K $20.13K Direct
Feb 17, 26
RIBEIRO RAMIRO
Officer
SELL 2.44K $36.55K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

7 reporting
NameRelationShares heldLatest
CORMORANT ASSET MANAGEMENT ,L.P
Unknown — Sale
DUKER JAY S
Chief Executive Officer 187.03K Conversion of Exercise of derivative security
ELSTON GEORGE O
Chief Financial Officer 219.16K Stock Gift
LANDIS JOHN B
Director 21.40K Conversion of Exercise of derivative security
LURKER NANCY S
Director 421.24K Conversion of Exercise of derivative security
RIBEIRO RAMIRO
Officer 0 Conversion of Exercise of derivative security
ZADEREJ KAREN L
Director 49.10K Purchase

Fundamentals

TTM · reported
Market cap$265.78M
Enterprise value$115.19M
Revenue (TTM)$2.79M
Gross profit$-257.47M
EBITDA$-314.38M
Net income$-306.64M
EPS (TTM)$-3.75
Free cash flow$-155.01M
Total cash$180.47M
Total debt$22.37M
Book value / share$1.96
Shares outstanding83.84M
Float60.67M
Short % of float24.18%
Dividend yield0.00%
Beta (5Y)1.68

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E-1.15
PEG ratio—
Price / sales—
Price / book1.62
EV / revenue41.32
EV / EBITDA-0.37
Gross margin0.00%
Operating margin-19207.10%
Profit margin0.00%
Return on equity-148.70%
Return on assets-74.85%
Debt / equity13.44
Current ratio4.50
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 5 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $31.37M$43.27M$46.02M$41.40M -27.5%
Operating revenue $31.37M$43.27M$46.02M$41.40M -27.5%
Cost of revenue $2.07M$3.71M$4.63M$8.33M -44.3%
Gross profit $29.30M$39.56M$41.39M$33.08M -25.9%
Research & development $221.04M$132.93M$64.66M$49.64M +66.3%
Selling, general & admin $51.70M$52.49M$51.79M$60.32M -1.5%
Total operating expense $272.74M$185.41M$116.45M$112.02M +47.1%
Operating income -$243.43M-$145.85M-$75.07M-$78.94M -66.9%
Net interest income $11.75M$15.07M$5.70M-$1.06M -22.0%
Pre-tax income -$231.68M-$130.78M-$70.71M-$102.25M -77.2%
Tax provision $279.00K$90.00K$83.00K$0 +210.0%
Net income -$231.96M-$130.87M-$70.80M-$102.25M -77.2%
Net income to common -$231.96M-$130.87M-$70.80M-$102.25M -77.2%
Basic EPS -3.17-2.32-1.82-2.74 -36.6%
Diluted EPS -3.17-2.32-1.82-2.74 -36.6%
EBIT -$231.65M-$130.77M-$69.47M-$99.06M -77.1%
EBITDA -$229.34M-$129.23M-$69.00M-$96.62M -77.5%
Basic shares 73.25M56.30M38.90M37.32M +30.1%
Diluted shares 73.25M56.30M38.90M37.32M +30.1%

Options analytics

Account required
Put / call volume
0.04
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
30.00
+846.4% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
3.91K
Contracts, this expiry
Put volume
151
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
22.50
4 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.96-1.09 -13.9%
Mar 2026 -0.81-0.99 -22.5%
Dec 2025 -0.75-0.81 -8.0%
Sep 2025 -0.77-0.85 -10.2%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.91 11 $233.08K -75.9%
Next quarter -0.81 11 $299.38K -51.7%
Current year -3.72 11 $1.72M -94.5%
Next year -2.76 11 $17.93M +943.3%

Analyst targets & ownership

Account required
Mean target$25.91
High target$68.00
Low target$4.00
Implied upside717.32%
Analyst count11
ConsensusNONE
Strong buy / Buy1 / 6
Hold6
Sell / Strong sell0 / 0
Held by insiders3.52%
Held by institutions117.64%
Institutions holding263
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
3.38
-6.19% from price
SMA 20
3.70
-14.21% from price
SMA 50
6.66
-52.37% from price
SMA 100
9.90
-67.97% from price
SMA 200
12.40
-74.43% from price
EMA 12
3.47
-8.70% from price
EMA 26
4.34
-26.93% from price
EMA 50
6.15
-48.45% from price
RSI (14)
29.0
Oversold
MACD (12,26,9)
-0.87
Hist 0.16
ATR (14)
0.27
8.65% of price
Realised vol 30D
82.0%
Annualised
Bollinger upper
4.49
20, 2σ
Bollinger lower
2.90
20, 2σ
50 / 200 cross
Death
6.66 vs 12.40
Trend bias
Below 200
-74.43%

Options chain

Account required
Expiry
Spot 3.17
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.32
More volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
82.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-83.3%
Peak to trough
Max drawdown 5Y
-89.4%
Peak to trough
ATR 14
0.27
8.65% of price
Beta (reported)
1.68
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
19.81M
Prior 18.43M
Change vs prior
+7.5%
Shorts adding
% of float
24.18%
Heavily shorted
% of shares out
22.98%
Against total outstanding
Days to cover
2.8
Liquid
Float
60.67M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

76 on file
DateFirm ActionFromTo
Sep 2, 26 TD Cowen DOWNGRADE Buy Hold
Aug 18, 26 Citigroup MAINTAINED Buy Buy
Aug 18, 26 RBC Capital DOWNGRADE Outperform Sector Perform
Aug 18, 26 Chardan Capital DOWNGRADE Buy Neutral
Aug 18, 26 HC Wainwright & Co. DOWNGRADE Buy Neutral
Aug 17, 26 JP Morgan DOWNGRADE Overweight Neutral
Aug 17, 26 Jefferies MAINTAINED Buy Buy
Aug 17, 26 Chardan Capital MAINTAINED Buy Buy
Aug 7, 26 Chardan Capital MAINTAINED Buy Buy
Aug 6, 26 Cantor Fitzgerald MAINTAINED Overweight Overweight
Aug 6, 26 HC Wainwright & Co. MAINTAINED Buy Buy
Jul 16, 26 Stifel INITIATED — Buy

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateDec 9, 2020
Last split1:10
Split dateDec 9, 2020

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.